Roberto Perricone
Overview
Explore the profile of Roberto Perricone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
138
Citations
2157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zagni E, Frassi M, Pagano Mariano G, Fusaro E, Lomater C, Medico P, et al.
BMC Health Serv Res
. 2022 Dec;
22(1):1537.
PMID: 36527051
Background: Psoriatic arthritis (PsA) is a chronic, immune-mediated, spondyloarthropathy characterised by musculoskeletal signs and symptoms with associated joint pain and tenderness. The average worldwide PsA prevalence is 133/100,000, while in...
2.
Gremese E, Ciccia F, Selmi C, Cuomo G, Foti R, Matucci-Cerinic M, et al.
Clin Exp Rheumatol
. 2022 Oct;
41(3):735-743.
PMID: 36226614
Objectives: To compare real-world persistence, effectiveness and tolerability of ustekinumab versus TNF inhibitors (TNFi) in psoriatic arthritis (PsA). Methods: One-year data from Italian subjects enrolled in the PsABio study (PsA...
3.
Colombo D, Frassi M, Pagano Mariano G, Fusaro E, Lomater C, Medico P, et al.
BMC Rheumatol
. 2022 Sep;
6(1):57.
PMID: 36089612
Background: Biologics have demonstrated efficacy in PsA in randomized clinical trials. More evidence is needed on their effectiveness under real clinical practice conditions. The aim of the present work is...
4.
Navarini L, Currado D, Marino A, Di Donato S, Biaggi A, Caso F, et al.
Sci Rep
. 2022 May;
12(1):7498.
PMID: 35525861
An accurate prediction of cardiovascular (CV) risk in patients with Axial Spondyloarthritis (axSpA) is a strong unmet need, as CV risk algorithms poorly perform in these subjects. The aim of...
5.
Colombo D, Frassi M, Pagano Mariano G, Fusaro E, Lomater C, Medico P, et al.
Womens Health Rep (New Rochelle)
. 2022 Mar;
3(1):162-171.
PMID: 35262053
Phenotypic features and outcome differences between sexes have been reported in psoriatic arthritis (PsA). However, little is known about sex differences in effectiveness of biologics in clinical practice. gender analysis...
6.
Navarini L, Currado D, Caso F, Costa L, Chimenti M, DAntonio A, et al.
Clin Exp Rheumatol
. 2021 Oct;
40(7):1285-1292.
PMID: 34665697
Objectives: Long-term quality of life (QoL) is significantly compromised in patients with psoriatic arthritis (PsA) and only partially improves achieving remission or low disease activity. The main aim of this...
7.
Chimenti M, Perricone C, DAntonio A, Ferraioli M, Conigliaro P, Triggianese P, et al.
Front Genet
. 2021 Aug;
12:671976.
PMID: 34447407
Spondyloarthritis (SpA) is a group of chronic inflammatory rheumatic disease that can be divided into predominantly axial or predominantly peripheral involvement, with or without associated psoriasis, inflammatory bowel disease or...
8.
Chimenti M, Conigliaro P, Caso F, Costa L, Ortolan A, Triggianese P, et al.
Clin Rheumatol
. 2021 Aug;
41(1):75-84.
PMID: 34410550
Objectives: To determine the effectiveness of golimumab (GLM) in improving joint, periarticular structures and cutaneous manifestations in patients with moderate to severe psoriatic arthritis (PsA) with cutaneous psoriasis in different...
9.
Di Marino M, Conigliaro P, Aiello F, Valeri C, Giannini C, Mancino R, et al.
J Ophthalmol
. 2021 Jul;
2021:2023246.
PMID: 34221491
Purpose: To evaluate the effects of combined intense pulsed light therapy (IPL) and low-level light therapy (LLLT) in dry eye disease (DED) in patients affected by Sjögren's syndrome. . This...
10.
Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni M, et al.
Biomedicines
. 2021 Jul;
9(6).
PMID: 34208130
Antiphospholipid antibodies (aPL) can induce fetal loss in experimental animal models. Human studies did find hypocomplementemia associated with pregnancy complications in patients with antiphospholipid syndrome (APS), but these results are...